Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A breast cancer clinical registry in an Italian comprehensive cancer center: an instrument for descriptive, clinical, and experimental research.
Baili P, Torresani M, Agresti R, Rosito G, Daidone MG, Veneroni S, Cavallo I, Funaro F, Giunco M, Turco A, Amash H, Scavo A, Minicozzi P, Bella F, Meneghini E, Sant M. Baili P, et al. Among authors: cavallo i. Tumori. 2015 Jul-Aug;101(4):440-6. doi: 10.5301/tj.5000341. Epub 2015 May 2. Tumori. 2015. PMID: 25953447
[Turn-over of non-tenured public health research personnel in an Italian public research institute (IRCCS).].
Meneghini E, Lillini R, Ballarini R, Florita A, Cavallo I, Funaro F, Bonfarnuzzo S, Cifalà A, Margutti C, Perrotta I, Bonacci P, Carletti F, Fracchiolla V, Morelli M, Aiello A, Pizzo F, Gabaldi P, Apolone G, Baili P. Meneghini E, et al. Among authors: cavallo i. Recenti Prog Med. 2019 Feb;110(2):75-85. doi: 10.1701/3112.31002. Recenti Prog Med. 2019. PMID: 30843532 Italian.
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
Niger M, Nichetti F, Fornaro L, Pircher C, Morano F, Palermo F, Rimassa L, Pressiani T, Berardi R, Gardini AC, Sperti E, Salvatore L, Melisi D, Bergamo F, Siena S, Mosconi S, Longarini R, Arcangeli G, Corallo S, Delliponti L, Tamberi S, Fea E, Brandi G, Rapposelli IG, Salati M, Baili P, Miceli R, Ljevar S, Cavallo I, Sottotetti E, Martinetti A, Busset MDD, Sposito C, Di Bartolomeo M, Pietrantonio F, de Braud F, Mazzaferro V. Niger M, et al. Among authors: cavallo i. BMC Cancer. 2024 May 6;24(1):563. doi: 10.1186/s12885-024-12328-0. BMC Cancer. 2024. PMID: 38711003 Free PMC article. No abstract available.
A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract Cancers (BTC) at high risk for recurrence: PURITY study.
Niger M, Nichetti F, Fornaro L, Pircher C, Morano F, Palermo F, Rimassa L, Pressiani T, Berardi R, Gardini AC, Sperti E, Salvatore L, Melisi D, Bergamo F, Siena S, Mosconi S, Longarini R, Arcangeli G, Corallo S, Delliponti L, Tamberi S, Fea E, Brandi G, Rapposelli IG, Salati M, Baili P, Miceli R, Ljevar S, Cavallo I, Sottotetti E, Martinetti A, Busset MDD, Sposito C, Di Bartolomeo M, Pietrantonio F, de Braud F, Mazzaferro V. Niger M, et al. Among authors: cavallo i. BMC Cancer. 2024 Apr 8;24(1):436. doi: 10.1186/s12885-024-12225-6. BMC Cancer. 2024. PMID: 38589856 Free PMC article. Clinical Trial.
Evidence of a SARS-CoV-2 double Spike mutation D614G/S939F potentially affecting immune response of infected subjects.
Donzelli S, Spinella F, di Domenico EG, Pontone M, Cavallo I, Orlandi G, Iannazzo S, Ricciuto GM, Isg Virology Covid Team, Pellini R, Muti P, Strano S, Ciliberto G, Ensoli F, Zapperi S, La Porta CAM, Blandino G, Morrone A, Pimpinelli F. Donzelli S, et al. Among authors: cavallo i. Comput Struct Biotechnol J. 2022;20:733-744. doi: 10.1016/j.csbj.2022.01.021. Epub 2022 Jan 21. Comput Struct Biotechnol J. 2022. PMID: 35096288 Free PMC article.
47 results